Cabazitaxel, a chemotherapy drug, plays a critical role in the treatment of metastatic prostate cancer, particularly for patients who no longer respond to conventional therapies. As a taxane-based chemotherapy, cabazitaxel works by inhibiting cell division, thereby slowing the growth of cancerous cells. Given its importance in oncology and the increasing …
Read More »